![Cancers | Free Full-Text | Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence Cancers | Free Full-Text | Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence](https://www.mdpi.com/cancers/cancers-14-03483/article_deploy/html/images/cancers-14-03483-g001-550.jpg)
Cancers | Free Full-Text | Association between Metabolic Disorders and Cholangiocarcinoma: Impact of a Postulated Risk Factor with Rising Incidence
![Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors - ScienceDirect Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169500215001725-gr2.jpg)
Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors - ScienceDirect
![Frontiers | Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma Frontiers | Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma](https://www.frontiersin.org/files/Articles/748557/fonc-12-748557-HTML/image_m/fonc-12-748557-g001.jpg)
Frontiers | Comprehensive Analysis Identified Mutation-Gene Signature Impacts the Prognosis Through Immune Function in Hepatocellular Carcinoma
![Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730420300012-gr1.jpg)
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect
![PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network](https://www.researchgate.net/publication/336972259/figure/fig3/AS:962802894262279@1606561506425/Kaplan-Meyer-curve-of-time-from-last-chemotherapy-cycle-to-date-of-progression-or-death_Q320.jpg)
PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network
![Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma](https://www.mdpi.com/cancers/cancers-14-02281/article_deploy/html/images/cancers-14-02281-g001.png)
Cancers | Free Full-Text | Spread Through Air Spaces (STAS) Is an Independent Prognostic Factor in Resected Lung Squamous Cell Carcinoma
![Viruses | Free Full-Text | Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma Viruses | Free Full-Text | Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma](https://www.mdpi.com/viruses/viruses-15-00198/article_deploy/html/images/viruses-15-00198-g001.png)
Viruses | Free Full-Text | Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma
![The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study](https://www.jcancer.org/v12/p5644/jcav12p5644g003.jpg)
The emergence of new prognostic scores in lung cancer patients with spinal metastasis: A 12-year single-center retrospective study
![Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730420300012-gr2.jpg)
Performance Status and Age as Predictors of Immunotherapy Outcomes in Advanced Non–Small-Cell Lung Cancer - ScienceDirect
![Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis - ScienceDirect Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0041008X2200182X-ga1.jpg)
Mogrol suppresses lung cancer cell growth by activating AMPK-dependent autophagic death and inducing p53-dependent cell cycle arrest and apoptosis - ScienceDirect
![PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network PDF) Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network](https://i1.rgstatic.net/publication/336972259_Treatment_beyond_four_cycles_of_first_line_Platinum_and_Etoposide_chemotherapy_in_real-life_patients_with_stage_IV_Small_Cell_Lung_Cancer_a_retrospective_study_of_the_Merseyside_and_Cheshire_Cancer_ne/links/5dbcd62b299bf1a47b0a4680/largepreview.png)